Cranioselectivity of sumatriptan revisited: Pronounced contractions to sumatriptan in small human isolated coronary artery

CNS Drugs

Volumn 28, Issue 3, 2014, Pages 273-278

  Chan, Kayi Y ^a   Labruijere, Sieneke ^a   Ramírez Rosas, Martha B ^a   De Vries, René ^a   Garrelds, Ingrid M ^a   Danser, Alexander H J ^a   Villalón, Carlos M ^b   Van Den Bogaerdt, Antoon ^a   Dirven, Clemens ^a   Maassenvandenbrink, Antoinette ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; CYCLIC AMP; FORSKOLIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SUMATRIPTAN; BIPHENYL DERIVATIVE; PIPERAZINE DERIVATIVE; PIPERIDONE DERIVATIVE; SB 22489G; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SPIRO COMPOUND; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTERY CONSTRICTION; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MENINGEAL ARTERY; PRIORITY JOURNAL; WESTERN BLOTTING; ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPHENYL COMPOUNDS; CHILD; COLFORSIN; CORONARY VESSELS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MENINGEAL ARTERIES; MIDDLE AGED; MUSCLE CONTRACTION; PIPERAZINES; PIPERIDONES; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SPIRO COMPOUNDS; SUMATRIPTAN; TISSUE CULTURE TECHNIQUES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84896841692     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-013-0136-0     Document Type: Article

References (15)

1. Humphrey PP. The discovery and development of the triptans, a major therapeutic breakthrough. Headache. 2008;48(5):685-7.
2. MaassenVanDenBrink A, van den Broek RW, de Vries R, Bogers AJ, Avezaat CJ, Saxena PR. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology. 2000;55(10):1524-30.
3. Villalón CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009;124(3):309-23.
4. Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache. 2004;44(Suppl 1):S20-30.
5. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98(1):25-30.
6. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 2002;39(5):847-51.
7. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet. 1998;351(9110):1165-9.
8. Chan KY, Edvinsson L, Eftekhari S, Kimblad PO, Kane SA, Lynch J, et al. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther. 2010;334(3):746-52.
9. Edvinsson L, Chan KY, Eftekhari S, Nilsson E, de Vries R, Saveland H, et al. Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia. 2010;30(10):1233-40.
10. Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE, Watts SW. 5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved. BMC Pharmacol. 2012;12:4.
11. 1B-receptors. Br J Clin Pharmacol. 1998;46(6):577-82.
12. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60(6):1259-87.
13. Winbury MM, Howe BB. Stenosis: regional myocardial ischemia and reserve. Ischaemic Myocardium and Antianginal Drugs. New York: Raven press; 1979.
14. Tfelt-Hansen P, Steiner TJ. Over-the-counter triptans for migraine: what are the implications? CNS Drugs. 2007;21(11):877-83.
15. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, Tijssen CC, Egberts AC. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. 2006;67(7):1128-34.